Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.700
-0.015 (-0.40%)
At close: Sep 18, 2026, 4:00 PM EDT
3.710
+0.010 (0.27%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $20.02 million as of September 18, 2026. Its market cap has increased by 0.19% in one year.
Market Cap
20.02M
Enterprise Value
190.75K
1-Year Change
0.19%
Ranking
Category
Stock Price
$3.70
ChartMarket Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $20.02M, an increase of 85.58%. That is a compound annual growth rate of 42.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 20.02M | -4.04% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 21.96M |
| Lantern Pharma | 21.86M |
| Tvardi Therapeutics | 21.61M |
| Radiopharm Theranostics | 21.59M |
| GridAI Technologies | 21.38M |
| Jasper Therapeutics | 21.10M |
| Chemomab Therapeutics | 20.29M |
| NewcelX | 19.52M |